In any case, the point of the article to raise a concern, not prove something. FDA is responsible for overseeing this. So far, it appears that were some irregul

In any case, the point of the article to raise a concern, not prove something. FDA is responsible for overseeing this. So far, it appears that were some irregularities with Ventavia and now they might be resolved. The article never said that this invalidated all Pfizer trial data or anything. But concern was justified and the article was needed to ensure better oversight.